Valéria C.C. Andrade

Author

Universidade Federal de São Paulo

Also Known As

Valeria C.C. Andrade, Valéria C.C. Andrade, Valéria C C Andrade, Valéria C. C. Andrade, Valéria C.C. Andrade

Publications

418

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de São Paulo Ludwig Cancer Research Fundação Faculdade de Medicina Cornell University

About

Valéria C.C. Andrade is an author at Universidade Federal de São Paulo specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	240
2	Immunology	3	3	186
3	Cell Biology	2	2	104
4	Health Sciences	1	1	18
5	Allergy	1	1	18

Valéria C.C. Andrade

Publications

408

Citations

H-Index

Page 1

	Year	Citations
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients. Valéria C.C. Andrade, André L. Vettore, R Felix, PubMed Hematological MalignancyLymphoid NeoplasiaCancer ImmunosurveillancePrognostic ImpactMedicine	2008	118
MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin Tricia Nardiello, Achim A. Jungbluth, Anna Mei, Clinical Cancer Research	2011	88
SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis R Felix, Gisele W. B. Colleoni, Otávia L. Caballero, Cancer Letters Hematological MalignancyOncologyMedicineSage AnalysisCancer Genomics	2009	54
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6). Hearn Jay Cho, Otávia L. Caballero, Sacha Gnjatic, PubMed ImmunologyPathologyPhysical InteractionAntigen ProcessingCancer Biology	2006	50
Prognostic Impact of Cancer Testis Antigens Expression in Advanced Stage Multiple Myeloma Patients. Valéria C.C. Andrade, André L. Vettore, Manuella S.S. Almeida, Blood	2007	37
Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma Valéria C.C. Andrade, André L. Vettore, Maria Regina Régis Silva, Experimental Hematology	2009	22
Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines Fabrício de Carvalho, Érico T. Costa, Anamaria A. Camargo, PLoS ONE	2011	21
Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. Fabrício de Carvalho, André L. Vettore, Riguel Jun Inaoka, PubMed Possible BenefitsImmunologyPathologyImmunotherapyHematological Malignancy	2011	18

Page 1